Chronic Morphine Treatment Increases StimulatoryBeta-2 Adrenoceptor Signaling in A431 Cells Stably Expressing the Mu Opioid Receptor

  1. Hermann Ammer and
  2. Rüdiger Schulz
  1. Institute of Pharmacology, Toxicology and Pharmacy, University of Munich, München, Germany

    Abstract

    Chronic opioid regulation of stimulatory beta-2 adrenoceptor (beta-2 AR) signaling was investigated in human mammary epidermoid carcinoma A431 cells stably expressing the cloned ratmu opioid receptor. In the cell clone used (A431/μ13;B max = 302.9 ± 46 fmol/mg membrane protein), the addition of morphine acutely attenuated basal as well as (−)-isoproterenol-stimulated cAMP accumulation. Prolonged exposure of the cells to morphine (10 μM; 2 d) resulted in homologous desensitization of MOR function as well as heterologous sensitization of adenylate cyclase (AC). Up-regulation of AC in A431/μ13 cells is characterized by an increased capacity rather than an increased sensitivity of beta-2 AR-stimulated AC. Moreover, opioid withdrawal fails to precipitate a cAMP overshoot in this cell system. Sensitization of stimulatory AC signaling by chronic morphine develops in a time- and dose-dependent manner and is blocked by both naloxone and pertussis toxin. Investigation into the mechanism leading to up-regulation of AC revealed a 40% increase in the number ofbeta-2 ARs as assessed by [125I]-cyanopindolol binding experiments. No additional quantitative changes were found for stimulatory G proteins and the effector enzyme itself. Sensitization of AC appears to be mediated solely by the increase inbeta-2 AR numbers, because (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride, which acts as an “inverse agonist” at thebeta-2 AR, completely reversed elevated basal AC activities, and because the ratio between functional active beta-2 ARs and stimulatory G proteins remained unchanged. In conclusion, chronic exposure of clonal A431/μ13 cells to morphine increases the capacity of stimulatory AC signaling by up-regulating beta-2 AR number. These results demonstrate participation of stimulatory receptor systems in the cellular mechanisms underlying opioid dependence.

    Footnotes

    • Send reprint requests to: Hermann Ammer, Institute of Pharmacology, Toxicology and Pharmacy, University of Munich, Königinstrasse 16, D-80539 München, Germany.

    • Abbreviations:
      AC
      adenylate cyclase
      beta-2AR
      adrenoceptor
      BSA
      bovine serum albumin
      CYP
      cyanopindolol
      DAGO
      [D-Ala2, MePhe4, Gly-ol5]enkephalin
      Gs’
      stimulatory G protein
      DMEM
      Dulbecco’s modified Eagle’s medium
      ICI 118
      551, (±)-1-[2, 3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride
      IBMX
      3-isobutyl-1-methylxanthine
      MOR
      mu-opioid receptor
      PTX
      pertussis toxin
      Ro 20-1724
      4-[(butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone
      • Received June 20, 1996.
      • Accepted September 13, 1996.
    « Previous | Next Article »Table of Contents